Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
ProMIS Neurosciences Inc (NASDAQ: PMN) closed the day trading at $0.33 down -22.36% from the previous closing price of $0.42. In other words, the price has decreased by -$22.36 from its previous closing price. On the day, 3.95 million shares were traded. PMN stock price reached its highest trading level at $0.348 during the session, while it also had its lowest trading level at $0.3.
Ratios:
For a better understanding of PMN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.76 and its Current Ratio is at 1.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 03 ’25 when Milbury Max A. bought 30,392 shares for $0.49 per share. The transaction valued at 14,929 led to the insider holds 45,389 shares of the business.
Cashman Neil bought 15,000 shares of PMN for $14,595 on Feb 10 ’25. The Chief Scientific Officer now owns 16,617 shares after completing the transaction at $0.97 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMN now has a Market Capitalization of 17547804 and an Enterprise Value of 2115587.
Stock Price History:
The Beta on a monthly basis for PMN is -0.08, which has changed by -0.54347825 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, PMN has reached a high of $1.59, while it has fallen to a 52-week low of $0.35. The 50-Day Moving Average of the stock is -24.73%, while the 200-Day Moving Average is calculated to be -42.46%.
Shares Statistics:
Over the past 3-months, PMN traded about 1.44M shares per day on average, while over the past 10 days, PMN traded about 633400 shares per day. A total of 53.81M shares are outstanding, with a floating share count of 20.96M. Insiders hold about 35.89% of the company’s shares, while institutions hold 12.17% stake in the company. Shares short for PMN as of 1761868800 were 277227 with a Short Ratio of 0.19, compared to 1759190400 on 320372. Therefore, it implies a Short% of Shares Outstanding of 277227 and a Short% of Float of 0.58999998.
Earnings Estimates
ProMIS Neurosciences Inc (PMN) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.2 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.6 and -$1.37 for the fiscal current year, implying an average EPS of -$1.12. EPS for the following year is -$0.71, with 4.0 analysts recommending between -$0.41 and -$1.02.
